Sarcopenia
Welcome,         Profile    Billing    Logout  
 46 Companies   12 Products   12 Products   17 Mechanisms of Action   756 Trials   22406 News 


«12...6667686970717273747576...401402»
  • ||||||||||  Journal:  Associations of micronutrient dietary patterns with sarcopenia among US adults: a population-based study. (Pubmed Central) -  Feb 27, 2024   
    In subgroup analysis, MN intake patterns were significantly correlated with sarcopenia in middle-aged females. Nutritional patterns based on MN intake were significantly related to sarcopenia, indicating that MNs interact with each other while exerting their individual functions, and that MN dietary patterns may provide promising strategies for preventing the loss of muscle mass, with further prospective studies warranted in the future.
  • ||||||||||  Journal:  Sarcopenic patients "get even": The impact of COVID-19 vaccination on mortality. (Pubmed Central) -  Feb 27, 2024   
    Our study represents the first attempt to analyze the vaccine's effect on survival in sarcopenic hospitalized older adults with COVID-19. The administration of vaccination to sarcopenic patients proves pivotal, as its omission could lead to notably unfavorable outcomes within this specific population.
  • ||||||||||  Journal:  Sarcopenia, sarcopenic obesity, and arterial stiffness among older adults. (Pubmed Central) -  Feb 26, 2024   
    In conclusion, a positive correlation is found between sarcopenia, SO, and arterial stiffness among older subjects. In particular, greater central arterial stiffness is associated with SO, outlining a remarkable effect on the cardiovascular risk profile.
  • ||||||||||  Journal:  Management Considerations for the Older Adult With Inflammatory Bowel Disease. (Pubmed Central) -  Feb 26, 2024   
    However, to help improve medical decision-making, clinicians must move away from the use of chronological age alone and begin to integrate measures of biological age, such as frailty and sarcopenia, into risk stratification tools. This article reviews the management considerations for older adults with IBD and provides the rationale for incorporating measures of biological age into current practice.
  • ||||||||||  Review, Journal:  Mitochondrial involvement in sarcopenia. (Pubmed Central) -  Feb 26, 2024   
    Based on the reported mitochondrial effects of therapeutic interventions, however, we argue that the observed bioenergetic changes may instead reflect an adaptation to pathologically decreased energy expenditure in sarcopenic muscle. Discrimination between these mechanistic possibilities will be crucial for improving the management of sarcopenia.
  • ||||||||||  Review, Journal:  Sarcopenia and Neuroendocrine Neoplasms. (Pubmed Central) -  Feb 26, 2024   
    The main findings of this review are to describe the presence of sarcopenia in patients with NENs. However, results should be interpreted with caution, and future research should focus on the correct technique, homogenous population and same time point.
  • ||||||||||  Review, Journal, Surgery:  Prevalence of dysphagia in patients after orthopedic surgery. (Pubmed Central) -  Feb 26, 2024   
    These results suggest non-neurogenic dysphagia in older patients undergoing orthopedic surgery and indicate that sarcopenia may contribute to postoperative dysphagia in this population. Therefore, further research should clarify the trajectory of postoperative dysphagia and the effectiveness of rehabilitation for postoperative dysphagia after orthopedic surgery.
  • ||||||||||  Review, Journal:  Sarcopenic obesity in cancer. (Pubmed Central) -  Feb 25, 2024   
    Reported prevalence of sarcopenic obesity in cancer varies because of heterogeneity in definitions and variability in diagnostic criteria used to estimate the prevalence of sarcopenia and obesity. Therefore, the aim of this review is to describe the definitions, prevalence, and diagnostic criteria as well as the mechanisms that cancer has in common with sarcopenic obesity.
  • ||||||||||  Retrospective data, Journal:  Incidence and risk factors of sarcopenia in hospitalized survivors of COVID-19; a retrospective cohort study. (Pubmed Central) -  Feb 24, 2024   
    Therefore, the aim of this review is to describe the definitions, prevalence, and diagnostic criteria as well as the mechanisms that cancer has in common with sarcopenic obesity. Sarcopenia should be closely monitored in patients with cases of severe inflammatory effect, inadequate food intake, and diminished physical activity such as hospitalized survivors of COVID-19.
  • ||||||||||  Journal, Pan tumor:  Tumor-Derived Sarcopenia Factors Are Diverse in Different Tumor Types: A Pan-Cancer Analysis. (Pubmed Central) -  Feb 24, 2024   
    Highly expressed secretory mediators in the tumor microenvironment were associated with SMA and could affect the overall survival of cancer patients, which may provide a valuable starting point for the further understanding of the molecular basis of muscle wasting in cancers. More importantly, tumor-derived pro-sarcopenic factors differ across tumor types and genders, which implies that mechanisms of cancer-associated muscle wasting are complex and diverse across tumors, and may require individualized treatment approaches.
  • ||||||||||  Journal:  Role of NLRP3 inflammasomes in musculoskeletal disorders (Pubmed Central) -  Feb 23, 2024   
    Therefore, investigating the mechanism and function of NLRP3 inflammasomes, holds great significance and importance for the prevention and treatment of musculoskeletal disorders. This review provides a summary of the activation pathway and mechanism of NLRP3 inflammasomes, and analyzes the role in musculoskeletal disorders such as sarcopenia, osteoporosis and arthritis, with the aim to facilitate the treatment of musculoskeletal disorders.
  • ||||||||||  Kremezin (AST-120) / Mitsubishi Tanabe
    Journal:  Pharmacologic therapeutics in sarcopenia with chronic kidney disease. (Pubmed Central) -  Feb 23, 2024   
    AST-120 prevented IS and PCA tissue accumulation, ameliorated muscle atrophy, improved exercise capacity and mitochondrial biogenesis, restored epithelial tight junction proteins, and reduced plasma endotoxin levels and markers of oxidative stress and inflammation. In a human study, the addition of AST-120 to standard treatment had modest beneficial effects on gait speed change and quality of life.
  • ||||||||||  Retrospective data, Journal, Metastases:  Skeletal muscle status and survival among patients with advanced biliary tract cancer. (Pubmed Central) -  Feb 23, 2024   
    Skeletal muscle quantity and quality and their serial changes were associated with survival outcomes in patients with advanced biliary tract cancer. Our data highlight the importance of designing nutritional and physical interventions for improvements in skeletal muscle status.
  • ||||||||||  Review, Journal:  Role of AMP deaminase in diabetic cardiomyopathy. (Pubmed Central) -  Feb 22, 2024   
    The detrimental effects of AMPD were manifested at times of increased cardiac workload by pressure loading. In this review, we briefly summarize the expression and functions of AMPD in the heart and discuss the roles of AMPD in diabetic cardiomyopathy, mainly focusing on contractile dysfunction caused by this disorder.
  • ||||||||||  Review, Journal:  The importance of taste on swallowing function. (Pubmed Central) -  Feb 22, 2024   
    Proper stimulation of umami receptors in organs other than taste buds may help maintain nutritional status and muscle mass. Umami receptors are therefore a potential therapeutic target for dysphagia.